Yes VLA is an exciting comparison. There is every possibility that RGS rerates in similar fashion once Progenza trials move closer to market penetration. Their Japanese partnership was very clever indeed and bodes well all things considered.
Exciting times ahead once the market wakes up to its potential
RGS Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
